Bioprinting Laboratories, Inc.

Bioprinting Laboratories, Inc.

生物技术

Dallas,Texas 333 位关注者

Innovation in Organoid Culture and Disease Modeling

关于我们

Bioprinting Laboratories Inc. focuses on generating multicellular mini-tissues (“organoids”) via “microarray 3D bioprinting” and rapidly screening compounds by multiplexed cell-based assays. We aim at commercializing pillar/perfusion plates and bioprinted organoids on the plates and generating predictive toxicity/efficacy data to serve global in vitro cell-based testing markets.

网站
https://www.3dbpl.com
所属行业
生物技术
规模
2-10 人
总部
Dallas,Texas
类型
私人持股
创立
2017

地点

Bioprinting Laboratories, Inc.员工

动态

  • 查看Bioprinting Laboratories, Inc.的公司主页,图片

    333 位关注者

    ?? Breakthrough in On-Chip Organoid Cryopreservation by Bioprinting Laboratories Inc.! ?? The cryopreservation of complex 3D organoids is challenging due to the limited diffusion of cryoprotective agents into the core of organoids, leading to low cell viability after thawing. Our innovative pillar plate allows on-chip cryopreservation of early-stage human brain organoids (HBOs) with high cell viability for developmental neurotoxicity assays. ????? Using our on-chip cryopreservation technique, we’ve streamlined the entire process—from cryopreservation and thawing to organoid culturing, testing, and imaging—all on one seamless pillar plate! The PSC cryopreservation kit, combined with our optimized incubation time, ensured exceptional post-thaw viability for HBOs, reducing the organoid generation time while maintaining structural integrity. ?? Special thanks to Ms. Mona Zolfaghar and our dedicated research team for making this advancement possible. For more details, check out our latest publication: https://lnkd.in/geKvZ32r. Unlock the future of organoid research with Bioprinting Laboratories, Inc.!

    • 该图片无替代文字
  • 查看Bioprinting Laboratories, Inc.的公司主页,图片

    333 位关注者

    ?? Revolutionizing Developmental Neurotoxicity (DNT) Testing with Dynamic Organoid Culture ?? Traditional in vitro cell models and animal studies have long been used to evaluate the neurotoxicity of chemicals. However, these methods often focus solely on acute toxicity or present physiological differences that limit their relevance to human brain development. Moreover, animal models are time-consuming, expensive, and ethically challenging. Enter human brain organoids—an emerging and promising alternative for assessing the effects of chemicals on the developing brain. Yet, conventional organoid culture systems come with challenges: low throughput, lack of reproducibility, limited maturity, and necrotic core formation due to poor nutrient and oxygen diffusion. Our pillar/perfusion plate technology is designed to overcome these limitations! By creating a dynamic culture environment with rapid, bidirectional flow, this innovative system enables the differentiation of cerebral organoids with enhanced proliferation, maturity, and viability. It’s an ideal solution for predictive DNT models and high-throughput compound screening, allowing for more accurate and ethical assessments of chemical toxicity. If you're working in DNT or neurotoxicity research, this is a game-changer. Let’s push the boundaries of what’s possible in brain organoid development! For more details, check out our publication: https://lnkd.in/gajvdSd3 #Organoids #Neuroscience #Toxicology #InVitroModels #DrugScreening #PerfusionCulture #Neurotoxicity #DevelopmentalNeurotoxicity #Innovation

    • 该图片无替代文字
  • 查看Bioprinting Laboratories, Inc.的公司主页,图片

    333 位关注者

    ???High-throughput co-culture of spheroids for metabolism-mediated neurotoxicity testing ?? In the quest to better understand the complex interplay between chemicals and their metabolites, traditional in vitro neurotoxicity testing has often fallen short, particularly in replicating hepatic biotransformation. To address this critical gap, we’ve developed a cutting-edge, high-throughput testing system that integrates metabolically competent HepaRG cell spheroids with 3D-cultured ReNcell VM using our innovative 384PillarPlate. By combining HepaRG cell spheroids in an ultralow attachment (ULA) 384-well plate with ReNcell VM spheroids on our 384PillarPlate and generating compound metabolites in situ, we could assess the neurotoxic potential of parent compounds and their metabolites. This approach can be extended to any spheroid co-culture for investigating organ communications and performing high-throughput, high-content imaging assays by using spheroids. ?? Read the full article: https://lnkd.in/gVrUggXt Looking forward to seeing how this technology will transform the landscape of drug safety testing! ?? ?? For more information, visit www.3dbpl.com #NeurotoxicityTesting #3DCellCulture #InVitroModels?#Biotransformation #PharmaceuticalInnovation #ToxicologyResearch #HighThroughputScreening

    • 该图片无替代文字
  • 查看Bioprinting Laboratories, Inc.的公司主页,图片

    333 位关注者

    ?? Excited to share our latest innovation in human liver organoid culture! Traditional Matrigel dome cultures of organoids in 6-/24-well plates are often costly, with limited reproducibility and throughput. To address these challenges, we have developed an innovative microarray 3D bioprinting protocol utilizing a pillar plate and a deep well plate. By suspending foregut cells in Matrigel and bioprinting them onto our pillar plate, we have significantly scaled up liver organoid production. This was achieved by integrating the pillar plate with a 384-deep well plate, resulting in remarkable reproducibility (CV 15-18%) and enhanced maturity at a 10-fold reduced culture volume. The synergy between the pillar plate and the deep well plate has facilitated a robust and functional liver organoid culture, exhibiting superior viability, morphology, and essential liver functions, including albumin secretion and CYP3A4 activity. Furthermore, liver organoids cultivated on the pillar plate have been utilized in high-throughput hepatotoxicity assays with drugs such as sorafenib and tamoxifen. This scalable and reproducible method paves the way for advanced predictive compound assessments in clinical and pharmacological research. ???? Read the article below: https://lnkd.in/g2yB3h9q For more information, visit: www.3dbpl.com #PillarPlate #LiverOrganoids #OrganoidCulture #HighThroughputScreening #BiomedicalInnovation #3DBioprinting

    • 该图片无替代文字
  • 查看Bioprinting Laboratories, Inc.的公司主页,图片

    333 位关注者

    ?? Enhance Your 3D Cell Culture with Our Innovative Pillar/Perfusion Plate! Discover how our?Pillar/Perfusion Plate?revolutionizes?dynamic 3D cell culture?by eliminating necrotic core and enhancing?cell growth, reproducibility, throughput, and user friendliness. This cutting-edge platform overcomes the limitations of traditional static 3D cell cultures, offering rapid diffusion and compatibility with common lab equipment. ?? Key Benefits: ↘ Reduced Necrotic Core and Improved Cell Growth: Rapid nutrient and oxygen diffusion. ? High Throughput: Ideal for large-scale screenings. ?? User-Friendly: Easy integration with existing lab equipment. Read the full study in?ACS Biomaterials Science & Engineering?and elevate your research today! https://lnkd.in/epQFKMtz For more information, visit www.3dbpl.com

    • 该图片无替代文字
  • 查看Bioprinting Laboratories, Inc.的公司主页,图片

    333 位关注者

    ?? Revolutionizing Brain Organoid Culture for High-Throughput Screening ?? We’re thrilled to share our latest manuscript published in Biofabrication, where a simple and robust method of embryoid body (EB) transfer and encapsulation in Matrigel has been demonstrated on our pillar plate for cerebral organoid culture. This innovative method tackles some of the biggest challenges in brain organoid culture, such as low throughput, high variability, and labor-intensive processes. Key Highlights: ?? Streamlined process: Eliminated the need for labor-intensive, multiple transfer, and encapsulation steps, making brain organoid culture more reliable and reproducible. ?? High success rate: Achieved a 95% - 100% success rate of spheroid transfer to the pillar plate by a sandwiching and inverting method. ?? Enhanced reproducibility in organoid culture: Achieved the coefficient of variation (CV) in brain organoid generation in the range of 9% - 19%, ensuring reliable results for your experiments. ?? Miniaturized organoid culture: Reduced culture medium volume 10 times by using the pillar plate and significantly enhanced assay throughput by enabling in situ organoid testing, imaging, and analysis. This approach not only alleviates variability in organoid culture but also paves the way for high-throughput compound screening in clinical and industrial settings. If you are unsatisfied with large scale Matrigel dome culture and want to enhance the throughput of your organoid-based assays, this is a must-read! https://lnkd.in/g3CB29PW For more information, visit www.3dbpl.com #PillarPlate #PerfusionPlate #BrainOrganoid #OrganoidCulture #HighThroughputScreening #BiomedicalInnovation

    • 该图片无替代文字
  • 查看Bioprinting Laboratories, Inc.的公司主页,图片

    333 位关注者

    ?? Request your free samples today! ?? Dear researchers, are you: Struggling with non-reproducible organoids? Frustrated with increased cell death in the core and decreased organoid maturity? Tired of manually embedding your organoids with ECM Matrix one by one? Fed up with complicated systems involving pumps and tubes for your dynamic organoid culture needs? It’s time for a change. Increase reproducibility, throughput, and organoid maturity—all with one simple solution. Our pillar/perfusion plates and accessories are designed to simplify your organoid and 3D cell culture processes. Say goodbye to complex setups and hello to enhanced reproducibility, boosted throughput, and improved organoid maturity—without the need for pumps or tubes. DM Bioprinting Laboratories, Inc. or Pranav Joshi or Vanga Manav or email us at [email protected] to request for free samples. Visit www.3dbpl.com for more information.

    Bioprinting Laboratories, Inc. | Sale of Pillar/Perfusion Plates

    Bioprinting Laboratories, Inc. | Sale of Pillar/Perfusion Plates

    https://3dbpl.com

相似主页